Alembic Pharma surges 3 per cent
Alembic Pharma surges 3 per cent

Alembic Pharma surges 3 per cent

Nidhi Jani Article rating: 5.0

Alembic Pharmaceuticals today informed the bourses that it has received the final USFDA approval for its abbreviated new drug application (ANDA) Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.7

The market opened in the red on 15th January, overall volumes in futures & options currently stand at 1.43 crore contracts with a turnover of Rs. 10,44,468.80 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 3.8

The market opened in the red on 15th January, overall volumes in futures & options currently stand at 1.43 crore contracts with a turnover of Rs. 10,44,468.80 crore.

Sun Pharma enters into agreement with Rockwell Medical
Sun Pharma enters into agreement with Rockwell Medical

Sun Pharma enters into agreement with Rockwell Medical

Apurva Joshi Article rating: 5.0

Sun Pharmaceuticals Limited has announced that one of its wholly-owned subsidiaries has entered into an exclusive licensing and supply agreement with Rockwell Medical Inc, to commercialise Rockwell's Triferic, a proprietary iron replacement and haemoglobin maintenance drug, for treating anaemia in hemodialysis patients in India.

Index trend and stocks in action on January 15, 2020
Index trend and stocks in action on January 15, 2020

Index trend and stocks in action on January 15, 2020

Karan Dsij Article rating: 5.0

The best strategy would be running the long positions with a trailing stop-loss of prior day low. In any case, if the Nifty closes below the breakout level of 12,250 then, the short-term weakness is possible. Stocks in news: Pidilite Industries, Lemon Tree, Godawari Power & Ispat, CSB Bank, National Peroxide, Bharti Airtel.

Dull start in offing
Dull start in offing

Dull start in offing

Karan Dsij Article rating: 5.0

For the last four trading sessions, the bulls have been marching higher and scaling to new heights. The phrase ‘market hit a new peak’ has become such a standard remark, that its absence on one day could hit market participants psyche more badly than any real fundamental factor.

BERGEPAINT gives symmetrical triangle breakout
BERGEPAINT gives symmetrical triangle breakout

BERGEPAINT gives symmetrical triangle breakout

Vinayak Gangule Article rating: 4.0

The stock of Berger Paints India Limited has given a symmetrical triangle breakout on the daily timeframe along with relatively higher volumes.

IndusInd Bank falls despite stable asset quality
IndusInd Bank falls despite stable asset quality

IndusInd Bank falls despite stable asset quality

Pratik Shastri Article rating: 4.0

The banking industries performance is decided on many factors such as asset quality (NPAs), deposit growth, loan book growth and provisions for probable defaults of the outstanding loan assets. The early trend of the third quarter performance as depicted from the results of IndusInd bank and Bandhan indicates that provisioning number may also decide the stock performance of the banks.

Honourable Arbitral Tribunal result favours GPIL
Honourable Arbitral Tribunal result favours GPIL

Honourable Arbitral Tribunal result favours GPIL

Geyatee Deshpande Article rating: 3.3

The honourable Arbitral Tribunal dismissed the claim made by Lauren Jyoti Private Limited (Lauren) which is an EPC Contractor, appointed by Godawari Green Energy Limited (GGEL).

Shares of Saksoft jump 7 per cent post rating upgrade
Shares of Saksoft jump 7 per cent post rating upgrade

Shares of Saksoft jump 7 per cent post rating upgrade

Anthony Fernandes Article rating: 4.0

On January 14, 2020 (Tuesday), Credit Analysis and Research Limited (CARE) assigned an upward rating to the long-term bank facilities of Saksoft Limited from 'CARE BBB+' to 'CARE A-'.

RSS
First22912292229322942296229822992300Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR